Merchant S - Search Results

1

Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia.

McGarry LJ, Merchant S, Nathwani D, Pawar V, DeLong K, Thompson D, Akhras K, Ingham M, Weinstein MC. McGarry LJ, et al. Among authors: merchant s. J Med Econ. 2010 Mar;13(1):142-7. doi: 10.3111/13696991003604108. J Med Econ. 2010. PMID: 20136579 Free article.

2

Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation.

Kongnakorn T, Mwamburi M, Merchant S, Akhras K, Caro JJ, Nathwani D. Kongnakorn T, et al. Among authors: merchant s. Curr Med Res Opin. 2010 Jan;26(1):17-24. doi: 10.1185/03007990903358980. Curr Med Res Opin. 2010. PMID: 19895363

3

Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia.

Merchant S, Gast C, Nathwani D, Lee M, Quintana A, Ketter N, Friedland I, Ingham M. Merchant S, et al. Clin Ther. 2008 Apr;30(4):717-33. doi: 10.1016/j.clinthera.2008.04.001. Clin Ther. 2008. PMID: 18498921 Clinical Trial.

4

Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators.

Kollef MH, Nathwani D, Merchant S, Gast C, Quintana A, Ketter N. Kollef MH, et al. Among authors: merchant s. Crit Care. 2010;14(3):R84. doi: 10.1186/cc9012. Epub 2010 May 10. Crit Care. 2010. PMID: 20459721 Free PMC article.

5

Outcomes and management costs in patients hospitalized for skin and skin-structure infections.

Itani KM, Merchant S, Lin SJ, Akhras K, Alandete JC, Hatoum HT. Itani KM, et al. Among authors: merchant s. Am J Infect Control. 2011 Feb;39(1):42-9. doi: 10.1016/j.ajic.2010.03.018. Epub 2010 Jul 29. Am J Infect Control. 2011. PMID: 20673598

6

Outcomes associated with initial versus later vancomycin use in patients with complicated skin and skin-structure infections.

Itani KM, Akhras KS, Stellhorn R, Quintana A, Budd D, Merchant S. Itani KM, et al. Among authors: merchant s. Pharmacoeconomics. 2009;27(5):421-30. doi: 10.2165/00019053-200927050-00006. Pharmacoeconomics. 2009. PMID: 19586079

7

Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients.

Marwick C, Broomhall J, McCowan C, Phillips G, Gonzalez-McQuire S, Akhras K, Merchant S, Nathwani D, Davey P. Marwick C, et al. Among authors: merchant s. J Antimicrob Chemother. 2011 Feb;66(2):387-97. doi: 10.1093/jac/dkq362. Epub 2010 Oct 5. J Antimicrob Chemother. 2011. PMID: 20926396

8

Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States.

Neil N, Merchant S, Provenzano D, Ogden K, Mody SH. Neil N, et al. Among authors: merchant s. J Med Econ. 2013;16(2):307-17. doi: 10.3111/13696998.2012.756401. Epub 2012 Dec 14. J Med Econ. 2013. PMID: 23216013 Free article.

9

Cost-effectiveness of ceftolozane/tazobactam plus metronidazole compared with piperacillin/tazobactam as empiric therapy for the treatment of complicated intra-abdominal infections based on the in-vitro surveillance of bacterial isolates in the UK.

Prabhu V, Foo J, Ahir H, Sarpong E, Merchant S. Prabhu V, et al. Among authors: merchant s. J Med Econ. 2017 Aug;20(8):840-849. doi: 10.1080/13696998.2017.1333960. Epub 2017 Jun 8. J Med Econ. 2017. PMID: 28532194 Free article.

10

Diabetic peripheral neuropathy: resource utilization and burden of illness.

Mehra M, Merchant S, Gupta S, Potluri RC. Mehra M, et al. Among authors: merchant s. J Med Econ. 2014 Sep;17(9):637-45. doi: 10.3111/13696998.2014.928639. Epub 2014 Jun 17. J Med Econ. 2014. PMID: 24888404 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

827 results

Search Page

Filters